143 related articles for article (PubMed ID: 27345001)
1. Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients.
Ishida M; Kakuta T; Miyakogawa T; Tatsumi R; Matsumoto C; Fukagawa M
Tokai J Exp Clin Med; 2016 Jun; 41(2):97-100. PubMed ID: 27345001
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluents.
Yokota S; Kumano K; Hyodo T; Sakai T; Izumi G; Hashimoto A; Shibata K; Wang H
Adv Perit Dial; 1998; 14():195-9. PubMed ID: 10649723
[TBL] [Abstract][Full Text] [Related]
4. Effect of the peritoneal dialysis prescription on pentosidine in children.
Bayazit AK; Vogt BA; Dell KM; Davis ID; Noyan A; Anarat A; Avner ED; Erhard P; Weiss MF
Pediatr Nephrol; 2003 Oct; 18(10):1049-54. PubMed ID: 12898376
[TBL] [Abstract][Full Text] [Related]
5. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
6. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients.
Kocak H; Gumuslu S; Ermis C; Mahsereci E; Sahin E; Gocmen AY; Ersoy F; Suleymanlar G; Yakupoglu G; Tuncer M
Am J Nephrol; 2008; 28(1):91-6. PubMed ID: 17914250
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
[TBL] [Abstract][Full Text] [Related]
9. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
10. Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.
Friedlander MA; Wu YC; Elgawish A; Monnier VM
J Clin Invest; 1996 Feb; 97(3):728-35. PubMed ID: 8609229
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of furosine and pentosidine in CAPD patients.
Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
[TBL] [Abstract][Full Text] [Related]
12. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
13. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
Friedlander MA; Wu YC; Schulak JA; Monnier VM; Hricik DE
Am J Kidney Dis; 1995 Mar; 25(3):445-51. PubMed ID: 7872323
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
15. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
[TBL] [Abstract][Full Text] [Related]
16. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients.
Kocak H; Gumuslu S; Sahin E; Ceken K; Gocmen YA; Yakupoglu G; Ersoy FF; Tuncer M
Nephrology (Carlton); 2009 Apr; 14(3):273-80. PubMed ID: 19076287
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis.
Eiselt J; Rajdl D; Racek J; Siroká R; Trefil L; Opatrná S
Artif Organs; 2010 May; 34(5):420-5. PubMed ID: 20633156
[TBL] [Abstract][Full Text] [Related]
18. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamada S; Shoji H; Takeuchi M; Ueda S; Matsui T; Adachi H; Okuda S; Yamagishi S
Pharmacol Res; 2009 Dec; 60(6):515-8. PubMed ID: 19450686
[TBL] [Abstract][Full Text] [Related]
20. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
